Promoter hypermethylation of p73 and p53 genes in cervical cancer patients among north Indian population

[1]  Seyed Ali Hosseini,et al.  Methylation Patterns of Rb1 and Casp-8 Promoters and Their Impact on Their Expression in Bladder Cancer , 2009, Cancer investigation.

[2]  A. Guimarães,et al.  Methylation of P16, P21, P27, RB1 and P53 genes in odontogenic keratocysts. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[3]  Y. Katayama,et al.  Aberrant promoter hypermethylation profile of cell cycle regulatory genes in malignant astrocytomas. , 2006, Oncology reports.

[4]  J. Lau,et al.  Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients , 2006, Journal of Clinical Pathology.

[5]  R. Liang,et al.  Infrequent epigenetic dysregulation of CIP/KIP family of cyclin-dependent kinase inhibitors in multiple myeloma , 2005, Leukemia.

[6]  M. Lizano,et al.  Epigenetics of cervical cancer. An overview and therapeutic perspectives , 2005, Molecular Cancer.

[7]  Mitsutoshi Nakamura,et al.  Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma. , 2005, Oral oncology.

[8]  T. Ratliff.  Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. , 2005, The Journal of urology.

[9]  E. J. Lee,et al.  Progressive methylation during the serrated neoplasia pathway of the colorectum , 2005, Modern Pathology.

[10]  P. Vogt,et al.  Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Califano,et al.  Quantitative Detection of Promoter Hypermethylation of Multiple Genes in the Tumor, Urine, and Serum DNA of Patients with Renal Cancer , 2004, Cancer Research.

[12]  H. Ngan,et al.  p73 Expression Is Associated with the Cellular Radiosensitivity in Cervical Cancer after Radiotherapy , 2004, Clinical Cancer Research.

[13]  Luoping Zhang,et al.  Hypermethylation of the 5′ CpG Island of the FHIT Gene Is Associated with Hyperdiploid and Translocation-Negative Subtypes of Pediatric Leukemia , 2004, Cancer Research.

[14]  Q. Tao,et al.  Promoter hypermethylation of the cyclin-dependent kinase inhibitor (CDKI) gene p21WAF1/CIP1/SDI1 is rare in various lymphomas and carcinomas. , 2004, Blood.

[15]  Y. Katayama,et al.  Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  J. Go.  Methylation Analysis of Cyclin-Dependent Kinase Inhibitor Genes in Primary Gastrointestinal Lymphomas , 2003, Modern Pathology.

[17]  M. Mansukhani,et al.  Frequent Promoter Methylation of CDH1, DAPK, RARB, and HIC1 Genes in Carcinoma of Cervix Uteri: Its Relationship to Clinical Outcome , 2003, Molecular Cancer.

[18]  Jan-Gowth Chang,et al.  Epigenetic changes of tumor suppressor genes, P15, P16, VHL and P53 in oral cancer. , 2003, Oncology reports.

[19]  Y. Tomita,et al.  Methylation of promoter region in p27 gene plays a role in the development of lymphoid malignancies. , 2003, International journal of oncology.

[20]  Eileen M. Burd,et al.  Human Papillomavirus and Cervical Cancer , 1988, The Lancet.

[21]  J. Issa,et al.  Lack of p21CIP1 DNA methylation in acute lymphocytic leukemia , 2002 .

[22]  G. Melino,et al.  p73: Friend or foe in tumorigenesis , 2002, Nature Reviews Cancer.

[23]  J. A. Castillejo,et al.  5' CpG island hypermethylation is associated with transcriptional silencing of the p21(CIP1/WAF1/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia. , 2002, Blood.

[24]  M. Barbacid,et al.  To cycle or not to cycle: a critical decision in cancer , 2001, Nature reviews. Cancer.

[25]  A. Kibel,et al.  Methylation and mutational analysis of p27kip1 in prostate carcinoma , 2001, The Prostate.

[26]  Mitsutoshi Nakamura,et al.  Frequent Alterations of the p14ARF and p16INK4a Genes in Primary Central Nervous System Lymphomas , 2001 .

[27]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[28]  Ook Joon Yoo,et al.  Methylation in the p53 Promoter Is a Supplementary Route to Breast Carcinogenesis: Correlation between CpG Methylation in the p53 Promoter and the Mutation of the p53 Gene in the Progression from Ductal Carcinoma In Situ to Invasive Ductal Carcinoma , 2001, Laboratory Investigation.

[29]  A. Gazdar,et al.  Aberrant methylation during cervical carcinogenesis. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  J. Bartek,et al.  Aberrant p27Kip1 promoter methylation in malignant melanoma , 2000, Oncogene.

[31]  Steffen Hauptmann,et al.  Proteasome inhibitors induce caspase‐dependent apoptosis and accumulationof p21WAF1/Cip1 in human immatureleukemic cells , 2000 .

[32]  L. Jeng,et al.  Mutational analysis of the p27(kip1) gene in hepatocellular carcinoma. , 2000, Cancer letters.

[33]  H. S. Kim,et al.  Detection of p16 gene alteration in cervical cancer using tissue microdissection and LOH study. , 1999, Cancer letters.

[34]  A. Gartel,et al.  Transcriptional regulation of the p21((WAF1/CIP1)) gene. , 1999, Experimental cell research.

[35]  Xinbin Chen,et al.  The potential tumor suppressor p73 differentially regulates cellular p53 target genes. , 1998, Cancer research.

[36]  L. Jin,et al.  DNA methylation regulates p27kip1 expression in rodent pituitary cell lines. , 1998, The American journal of pathology.

[37]  S. Hirohashi,et al.  Reduced p27Kip1 expression in hepatocellular carcinomas. , 1998, Cancer letters.

[38]  D. Saranath,et al.  Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. , 1998, Oral oncology.

[39]  S. Groshen,et al.  Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. , 1998, Journal of the National Cancer Institute.

[40]  Braking the cell cycle , 1998, Science.

[41]  A. Yang,et al.  Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers , 1997, Cell.

[42]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[43]  S. Elledge,et al.  Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5. , 1996, Oncogene.

[44]  J. Herman,et al.  Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. , 1996, Cancer research.

[45]  F. Miller,et al.  Tumor suppression by p21WAF1. , 1995, Cancer research.

[46]  H. Koeffler,et al.  Role of the cyclin-dependent kinase inhibitors in the development of cancer. , 1995, Blood.

[47]  K. Kohn,et al.  Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells. , 1995, Cancer research.

[48]  B. Vogelstein,et al.  Absence of WAF1 mutations in a variety of human malignancies. , 1994, Blood.

[49]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[50]  P. Jeffrey,et al.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.

[51]  Yi-Song Wang,et al.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. , 1994, Cancer research.

[52]  T. Hunter.  Braking the cycle , 1993, Cell.

[53]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.

[54]  A. Knudson.  Retinoblastoma: a prototypic hereditary neoplasm. , 1978, Seminars in oncology.

[55]  Shailesh Kumar,et al.  Epigenetics and its role in ageing and cancer , 2011 .

[56]  J. Kaur,et al.  Reversal of hypermethylation and reactivation of the RARβ2 gene by natural compounds in cervical cancer cell lines. , 2010, Folia biologica.

[57]  E. J. Lee,et al.  Methylation of p16INK4A and p57KIP2 are involved in the development and progression of gastric MALT lymphomas , 2006, Modern Pathology.

[58]  Y. Kwong,et al.  Specific patterns of gene methylation in natural killer cell lymphomas : p73 is consistently involved. , 2002, The American journal of pathology.

[59]  J. Issa,et al.  Lack of p21(CIP1) DNA methylation in acute lymphocytic leukemia. , 2002, Blood.

[60]  J. A. Castillejo,et al.  CpG island hypermethylation is associated with transcriptional silencing of the p 21 CIP 1 / WAF 1 / SDI 1 gene and confers poor prognosis in acute lymphoblastic leukemia , 2002 .

[61]  H. Nakase,et al.  Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas. , 2001, Cancer research.

[62]  S. Hauptmann,et al.  Proteasome inhibitors induced caspase-dependent apoptosis and accumulation of p21WAF1/Cip1 in human immature leukemic cells. , 2000, European journal of haematology.

[63]  J. Herman,et al.  CpG Island Methylation ′ Associated with 5 Lymphoblastic Leukemia and Burkitt ' s Lymphoma Is Gene in Acute p 73 Transcriptional Silencing of the Updated Version , 1999 .

[64]  F. Behm,et al.  Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosis. , 1999, Blood.

[65]  近藤 征史.  Selective maternal-allele loss in human lung cancers of the maternally expressed p57[KIP2] gene at 11p15.5 , 1998 .

[66]  E. Campo,et al.  Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. , 1997, Blood.

[67]  C. Harris,et al.  Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment. , 1996, Preventive medicine.